McGill researchers develop ‘life-saving’ way to stop bleeding fast
Researchers in Montreal have developed a way to help control severe bleeding and improve treatment for people with clotting disorders, though they say it could still take time before it’s used in clinical settings.
Called “click clotting,” the aim is to use a person’s own blood or donor blood to make a stronger blood clot through a chemical reaction to help control bleeding faster than what is currently used.
“We need to manage the heavy bleeding, also known as hemorrhage, and the existing approach has limitations,” said Dr. Jianyu Li, senior author of the research and mechanical engineering professor at McGill University.
Read more to find out about the research.
— THE TOPIC —
With Canada approving 1st generic semaglutide, how will costs compare?
Health Canada approved the first generic version of brand-name semaglutide drugs like Ozempic on Tuesday, becoming the first G7 country to do so.
Manufactured by Dr. Reddy’s Laboratories in India, the injectable medication has been approved for once-a-week treatment of Type 2 diabetes in adults.
The generic semaglutide drug is sold under the brand name “Obeda” in India and was submitted for review to Health Canada in early 2024.
Read more to find out how the costs compare.
